Gene · 7045
Papers3,774
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,774
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer. | J Ovarian Res | 2023 | 37122030 | PubTator, text mining | PubMed |
| Vitamin K and the Visual System-A Narrative Review. | Nutrients | 2023 | 37111170 | PubTator, text mining | PubMed |
| Circulating microRNA Biomarker for Detecting Breast Cancer in High-Risk Benign Breast Tumors. | Int J Mol Sci | 2023 | 37108716 | PubTator, text mining | PubMed |
| Comparative Analysis of Epididymis Cauda of Yak before and after Sexual Maturity. | Animals (Basel) | 2023 | 37106918 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer. | Evid Based Complement Alternat Med | 2023 | 37101716 | PubTator, text mining | PubMed |
| Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in Glioblastoma. | Cancer Res | 2023 | 37101376 | PubTator, text mining | PubMed |
| Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. | Cancer Res | 2023 | 37098922 | PubTator, text mining | PubMed |
| An integrated bioinformatic analysis of bulk and single-cell sequencing clarifies immune microenvironment and metabolic profiles of lung adenocarcinoma to predict immunotherapy efficacy. | Front Cell Dev Biol | 2023 | 37091977 | PubTator, text mining | PubMed |
| Personalized regenerative strategies and molecular diagnosis for in vitro fertilization success: a case report. | Oxf Med Case Reports | 2023 | 37091684 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis uncovers diverse and dynamic senescent cell populations. | Aging (Albany NY) | 2023 | 37086265 | PubTator, text mining | PubMed |
| Thygeson's superficial punctate keratitis in children. | Eye (Lond) | 2023 | 37085721 | PubTator, text mining | PubMed |
| Construction of inflammatory associated risk gene prognostic model of NSCLC and its correlation with chemotherapy sensitivity. | Ann Med | 2023 | 37083272 | PubTator, text mining | PubMed |
| Construction of the Interaction Network of Hub Genes in the Progression of Barrett's Esophagus to Esophageal Adenocarcinoma. | J Inflamm Res | 2023 | 37077220 | PubTator, text mining | PubMed |
| Nonmuscle myosin IIB is a driver of cellular reprogramming. | Mol Biol Cell | 2023 | 37074945 | PubTator, text mining | PubMed |
| Clustering and machine learning-based integration identify cancer associated fibroblasts genes' signature in head and neck squamous cell carcinoma. | Front Genet | 2023 | 37065499 | PubTator, text mining | PubMed |
| A bibliometric analysis of ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer from 2012 to 2022. | Cell Death Discov | 2023 | 37061535 | PubTator, text mining | PubMed |
| CEBPD is a master transcriptional factor for hypoxia regulated proteins in glioblastoma and augments hypoxia induced invasion through extracellular matrix-integrin mediated EGFR/PI3K pathway. | Cell Death Dis | 2023 | 37059730 | PubTator, text mining | PubMed |
| Non-allergic eye rubbing is a major behavioral risk factor for keratoconus. | PLoS One | 2023 | 37053215 | PubTator, text mining | PubMed |
| Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. | J Clin Invest | 2023 | 37053016 | PubTator, text mining | PubMed |
| Highlighting In Vitro the Role of Brain-like Endothelial Cells on the Maturation and Metabolism of Brain Pericytes by SWATH Proteomics. | Cells | 2023 | 37048083 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7045/papers?page=25